Health-Related Quality of Life in Patients With Metastatic Basal Cell Carcinoma TreatedWith Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial
07:30am - 03:45pm EDT - March 31, 2023


Display Label Action
055-General Poster Session Download Handout